DO
Therapeutic Areas
Belyntic Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CMV Vaccine | Cytomegalovirus infection/reactivation in immunocompromised patients (e.g., transplant recipients) | Pre-clinical |
| JCV Vaccine | John Cunningham virus reactivation leading to Progressive Multifocal Leukoencephalopathy (PML) | Pre-clinical |